What Is the Optimal Duration of Antiplatelet Therapy for Patients with Coronary Heart Disease?

被引:3
作者
Otieno, Beryl [1 ]
Ibecheozor, Chukwuka [2 ]
Williams, Marlene S. S. [3 ]
机构
[1] Greater Baltimore Med Ctr, Towson, MD USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[3] Johns Hopkins Univ, Div Cardiol, Sch Med, 301 Mason Lord Dr,Suite 2400, Baltimore, MD 21224 USA
关键词
Antiplatelet therapy; Ischemia; Dual antiplatelet therapy; Bleeding; Coronary heart disease; DRUG-ELUTING STENTS; RANDOMIZED CLINICAL-TRIALS; EXTERNAL VALIDATION; DAPT SCORE; IMPLANTATION; CLOPIDOGREL; TICAGRELOR; MORTALITY; MONOTHERAPY; OUTCOMES;
D O I
10.1007/s11883-023-01108-z
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Purpose of ReviewOptimal duration of antiplatelet therapy continues to attract extensive debates and has been progressively adjusted in the setting of advancements in stent design and assessment of patient clinical characteristics. Given the ever-changing landscape of antiplatelet therapy and the multitude of clinical trials that have examined this duration, there are varying scenarios for optimal duration based on patient presentation and risk profile. This review highlights the current concepts and recommendations regarding duration of antiplatelet therapy in coronary heart disease.Recent FindingsIn particular, we review the current data on the use of dual antiplatelet therapy in the different clinical scenarios. Relatively longer dual antiplatelet therapy is perhaps limited to patients with higher risk for cardiovascular events and/or high-risk lesions and shorter durations of dual antiplatelet therapy have been shown to reduce bleeding complications at the same time as stabilization of ischemic endpoints.More recent trials have demonstrated the safety of shorter durations of dual antiplatelet therapy in appropriate patients with coronary heart disease.
引用
收藏
页码:343 / 350
页数:8
相关论文
共 46 条
[1]   P2Y12 inhibitor versus aspirin monotherapy for secondary prevention of cardiovascular events: meta-analysis of randomized trials [J].
Aggarwal, Devika ;
Bhatia, Kirtipal ;
Chunawala, Zainali S. ;
Furtado, Remo H. M. ;
Mukherjee, Debabrata ;
Dixon, Simon R. ;
Jain, Vardhmaan ;
Arora, Sameer ;
Zelniker, Thomas A. ;
Navarese, Eliano P. ;
Mishkel, Gregory J. ;
Lee, Cheong J. ;
Banerjee, Subhash ;
Bangalore, Sripal ;
Levisay, Justin P. ;
Bhatt, Deepak L. ;
Ricciardi, Mark J. ;
Qamar, Arman .
EUROPEAN HEART JOURNAL OPEN, 2022, 2 (02)
[2]   2022 ACC/AHA Key Data Elements and Definitions for Chest Pain and Acute Myocardial Infarction [J].
Anderson, H. V. ;
Masri, Sofia Carolina ;
Abdallah, Mouin S. ;
Chang, Anna Marie ;
Cohen, Mauricio G. ;
Elgendy, Islam Y. ;
Gulati, Martha ;
LaPoint, Kathleen ;
Madan, Nidhi ;
Moussa, Issam D. ;
Ramirez, Jorge ;
Simon, April W. ;
Singh, Vikas ;
Waldo, Stephen W. ;
Williams, Marlene S. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (17) :1660-1700
[3]   Diagnosis and Treatment of Acute Coronary Syndromes A Review [J].
Bhatt, Deepak L. ;
Lopes, Renato D. ;
Harrington, Robert A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (07) :662-675
[4]   Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial [J].
Bhatt, Deepak L. ;
Steg, Philippe Gabriel ;
Mehta, Shamir R. ;
Leiter, Lawrence A. ;
Simon, Tabassome ;
Fox, Kim ;
Held, Claes ;
Andersson, Marielle ;
Himmelmann, Anders ;
Ridderstrale, Wilhelm ;
Chen, Jersey ;
Song, Yang ;
Diaz, Rafael ;
Goto, Shinya ;
James, Stefan K. ;
Ray, Kausik K. ;
Parkhomenko, Alexander N. ;
Kosiborod, Mikhail N. ;
McGuire, Darren K. ;
Harrington, Robert A. .
LANCET, 2019, 394 (10204) :1169-1180
[5]   Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events [J].
Bhatt, DL ;
Fox, KAA ;
Hacke, W ;
Berger, PB ;
Black, HR ;
Boden, WE ;
Cacoub, P ;
Cohen, EA ;
Creager, MA ;
Easton, JD ;
Flather, MD ;
Haffner, SM ;
Hamm, CW ;
Hankey, GJ ;
Johnston, SC ;
Mak, KH ;
Mas, JL ;
Montalescot, G ;
Pearson, TA ;
Steg, PG ;
Steinhubl, SR ;
Weber, MA ;
Brennan, DM ;
Fabry-Ribaudo, L ;
Booth, J ;
Topol, EJ ;
Frye, RL ;
Amarenco, P ;
Brass, LM ;
Buyse, M ;
Cohen, LS ;
DeMets, DL ;
Fuster, V ;
Hart, RG ;
Marler, JR ;
McCarthy, C ;
Schoemig, A ;
Lincoff, AM ;
Brener, SJ ;
Sila, CA ;
Albuquerque, A ;
Aroutiounov, G ;
Artemiev, D ;
Atkeson, BG ;
Bartel, T ;
Basart, DCG ;
Lima, AB ;
Belli, G ;
Bordalo e Sa, AL ;
Bosch, X .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (16) :1706-1717
[6]   P2Y12 inhibitors monotherapy after short course of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized clinical trials including 29 089 patients [J].
Bianco, Matteo ;
Careggio, Alessandro ;
Destefanis, Paola ;
Luciano, Alessia ;
Perrelli, Maria Giulia ;
Quadri, Giorgio ;
Rossini, Roberta ;
Campo, Gianluca ;
Vizzari, Giampiero ;
D'Ascenzo, Fabrizio ;
Anselmino, Matteo ;
Biondi-Zoccai, Giuseppe ;
Ibanez, Borja ;
Montagna, Laura ;
Varbella, Ferdinando ;
Cerrato, Enrico .
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (03) :196-205
[7]   Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction [J].
Bonaca, Marc P. ;
Bhatt, Deepak L. ;
Cohen, Marc ;
Steg, Philippe Gabriel ;
Storey, Robert F. ;
Jensen, Eva C. ;
Magnani, Giulia ;
Bansilal, Sameer ;
Fish, M. Polly ;
Im, Kyungah ;
Bengtsson, Olof ;
Ophuis, Ton Oude ;
Budaj, Andrzej ;
Theroux, Pierre ;
Ruda, Mikhail ;
Hamm, Christian ;
Goto, Shinya ;
Spinar, Jindrich ;
Nicolau, Jose Carlos ;
Kiss, Robert G. ;
Murphy, Sabina A. ;
Wiviott, Stephen D. ;
Held, Peter ;
Braunwald, Eugene ;
Sabatine, Marc S. ;
Morin, Suzanne ;
Dantzer, Emily ;
Acquilano, Dayle ;
McGuire, Rachael L. ;
Gannon, Joseph B. ;
Gershman, Elaine ;
Ahlbom, Ann Maxe ;
Boberg, Barbro ;
Abola, Maria Teresa ;
Ardissino, Diego ;
Aylward, Philip ;
Corbalan, Ramon ;
Dalby, Anthony ;
Diaz, Rafael ;
Hu, Dayi ;
Isaza, Daniel ;
Kamensky, Gabriel ;
Kiss, Robert ;
Kontny, Frederic ;
Lopez-Sendon, Jose ;
Medina, Felix ;
Montalescot, Gilles ;
Nicolau, Jose ;
Paolasso, Ernesto ;
Parkhomenko, Alexander .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (19) :1791-1800
[8]   Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus [J].
Capodanno, Davide ;
Angiolillo, Dominick J. .
CIRCULATION, 2020, 142 (22) :2172-2188
[9]   Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI A Prespecified TWILIGHT Substudy [J].
Chiarito, Mauro ;
Baber, Usman ;
Cao, Davide ;
Sharma, Samin K. ;
Dangas, George ;
Angiolillo, Dominick J. ;
Briguori, Carlo ;
Cohen, David J. ;
Dudek, Dariusz ;
Dzavik, Vladimir ;
Escaned, Javier ;
Gil, Robert ;
Hamm, Christian W. ;
Henry, Timothy ;
Huber, Kurt ;
Kastrati, Adnan ;
Kaul, Upendra ;
Kornowski, Ran ;
Krucoff, Mitchell ;
Kunadian, Vijay ;
Mehta, Shamir R. ;
Moliterno, David ;
Ohman, E. Magnus ;
Oldroyd, Keith ;
Sardella, Gennaro ;
Zhang Zhongjie ;
Sartori, Samantha ;
Stefanini, Giulio ;
Shlofmitz, Richard ;
Steg, P. Gabriel ;
Weisz, Giora ;
Witzenbichler, Bernhard ;
Han, Ya-Ling ;
Pocock, Stuart ;
Gibson, C. Michael ;
Mehran, Roxana .
JACC-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (03) :282-293
[10]   PREDICTIVE ABILITY OF THE PARIS RISK SCORE IN ALL-COMERS PATIENTS UNDERGOING PCI WITH DRUG ELUTING STENTS: EXTERNAL VALIDATION IN THE GLOBAL LEADERS STUDY [J].
Chichareon, Ply ;
Baber, Usman ;
Modolo, Rodrigo ;
Chang, Chun-Chin ;
Kogame, Norihiro ;
Takahashi, Kuniaki ;
Tomaniak, Mariusz ;
Katagiri, Yuki ;
Curello, Salvatore ;
Galasko, Gavin ;
Leibundgut, Gregor ;
Umans, Victor ;
Friedrich, Guy ;
Seidler, Tim ;
Spitzer, Ernest ;
Onuma, Yoshinobu ;
Steg, Philippe ;
Hamm, Christian ;
Juni, Peter ;
Vranckx, Pascal ;
Valgimigli, Marco ;
Windecker, Stephan ;
van Klaveren, David ;
Mehran, Roxana ;
Serruys, Patrick .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) :245-245